JOURNAL OF CLINICAL SURGERY ›› 2021, Vol. 29 ›› Issue (11): 1089-1091.doi: 10.3969/j.issn.1005-6483.2021.11.027

Previous Articles     Next Articles

Advances in immune microenvironment and immunotherapy of hepatocellular carcinoma

  

  1. Hepatic Surgery Center,Tongji Hospital,Tongji Medical College Huazhong University of Science and Technology,Wuhan 430030,China
  • Online:2021-11-20 Published:2021-11-20

Abstract: Hepatocellular carcinoma(HCC) is one of the most common malignancies and a variety of factors can contribute to the occurrence and development of HCC.Among them,changes in the immune microenvironment may play an important role in recurrence and metastasis,immune escape and immune resistance of HCC.In recent years,immunotherapy represented by immune checkpoint inhibitors,adoptive cell therapy and tumor vaccine has brought new hope to patients with HCC.This review is focused on the research progress on the impacts of different immune cells of tumor microenvironment on the occurrence and development of HCC and the efficacy of different immunotherapies,as well as the outlook of immunotherapy trend.

Key words: hepatocellular carcinoma, immunotherapy, tumor microenvironment, immune checkpoint Inhibitors, adoptive transfer

Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] YUAN Xiaoyi. Erbium laser in the treatment of stress urinary incontinence[J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(2): 113 -115 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 999 -1000 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 1001 .
[4] LIN Ximeng, CHEN Minshan. Clinical features and diagnostic criteria of hepatobiliary duct cell carcinoma[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1004 -1007 .
[5] HUANG Cheng, SUN Huichuan. The road to radical cure in advanced hepatocellular carcinoma——conversion therapy[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1008 -1011 .
[6] WANG Guanyu. Conversion therapy for hepatocellular carcinoma: strategies and current status[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1012 -1014 .
[7] WANG Xiaofei, LI Debao, XIA Feng. Evaluation and research progress of residual liver volume after hepatectomy[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1015 -1018 .
[8] CHEN Jiye, SU Ming, HAN Jun, et al. Laparoscopic anatomic segmental resection of liver[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1018 -1021 .
[9] LIU Zhicheng, GUO Bin, ZHOU Yi, et al. Perioperative adjuvant therapy for hepatocellular carcinoma[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1022 -1024 .
[10] REN Zhangyong, LV Shaocheng, CAO Di, et al.. Pathogenic characteristics and drug resistance of vancomycin resistant enterococci after liver transplantation[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1025 -1028 .